Systemic Sclerosis: Successful Treatment of Ulcerations,Pain,Raynaud's Phenomenon,Calcinosis,and Dysphagia by Transcutaneous Nerve Stimulation: * A Case Report
Restricted accessResearch articleFirst published online February, 1984
Systemic Sclerosis: Successful Treatment of Ulcerations,Pain,Raynaud's Phenomenon,Calcinosis,and Dysphagia by Transcutaneous Nerve Stimulation: * A Case Report
Transcutaneous nerve stimulation (TNS) has previously been shown to improve microcirculation in ischemic limbs of patients with Raynaud's phenomenon and diabetic neuropathy and to accelerate healing of chronic skin ulcerations. The present report deals with a patient with systemic sclerosis in which Raynaud's phenomenon, ulcerations and pains in the feet, calcinosis and dysphagia have been successfully treated by TNS. The mechanisms implicated are discussed.
AlumetsJ., FahrenkrugJ.HåkansonR.., A rich VIP nerve supply is characteristic of sphincters, Nature, 156, 155–156, 1979.
2.
BryantM.G.PolakJ.M. Modlin ., Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance, Lancet, i, 991–993, 1976.
3.
DomschkeW.LuxG.DomschkeS.., Effects of vasoactive intestinal peptide on resting and pentagin-stimulated lower esophageal sphincter pressure, Gastroenterology, 75, 9–12, 1978.
4.
FahrenkrugJ.and Schaffalitzky de MuckadellD.B., Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma, J. Lab. Clin. Med., 89, 1378–1388, 1977.
5.
FoxJ.SaidS.I.and DanialE.E. Is vasoactive intestinal polypeptide (VIP) an inhibitory neurotransmitter in the lower esophageal sphincter (LES) in North American opposum? Gastroenterology, 761134, 1979.
6.
GillilandB.C.and MannikM. Progressive systemic sclerosis (diffuse scleroderma), pp. 1896–19Q0 in Harrison's Principles of Internal Medicine, McGraw-Hill Book Co., New York, 9th ed., 1980. '
7.
GoyalR.K.SaidS.I.and RattanS.Influence of VIP antiserum on lower esophageal sphincter relaxation: Possible evidence for VIP as the inhibitory neuro-transmitter, Gastroenterology, 761142, 1979.
8.
HarrisE.D.Jr., Systemic sclerosis (scleroderma), pp. 168–171in Cecil; Textbook of Medicine, P.B. Beeson, W. McDermott and J.B. Wyngaarden, eds., W.B. Saunders Co., Philadelphia, London, Toronto, 15th ed., 1979.
9.
KaadaB.Vasodilation induced by transcutaneous nerve stimulation in peripheral ischemia (Raynaud's phenomenon and diabetic polyneuropathy), Eur. Heart J., 3, 303–314, 1983.
10.
KaadaB.Treatment of peripheral circulatory disturbances and chronic skin ulcers by transcutaneous nerve stimulation (TNS), (In Norwegian with English summary), Tidsskr. Nor. Laegeforen., 102, 1563–1570 and 1591, 1982.
11.
KaadaB. Neurophysiological mechanisms of pain suppression and cutaneous vasodilation induced by transcutaneous nerve stimulation (TNS) and acupuncture - A review, pp. 64–94 in “Legevitenskap og livsvisdom”, Festschrift to Tollak B. Sirnes on his 60th anniversary, October 17. 1982, University Press, Bergen, Norway, 1982. (Reprints available from the author).
12.
KaadaB.Promoted healing of chronic ulceration by transcutaneous nerve stimulation (TNS), VASA, 12, 262–269, 1983.
13.
KaadaB.and EielsenO.In search of mediators of skin vasodilation induced by transcutaneous nerve stimulation: I. Failure to block the response by antagonists of endogenous vasodilators, Gen. Pharmacol., 14, 623–633, 1983.
14.
KaadaB.and EielsenO.In search of mediators of skin vasodilation induced by transcutaneous nerve stimulation: II. Serotonin implicated, Gen. Pharmacol., 14, 635–641, 1983.
15.
KaadaB.OlsenE.and EielsenO., In search of mediators of skin vasodilation induced by transcutaneous nerve stimulation: III. Increase in plasma VIP in normal subjects and in Raynaud's disease, Gen. Pharmacol., 15, 107–113, 1984.
16.
KaadaB.and HelleK.In search of mediators of skin vasodilation induced by transcutaneous nerve stimulation: IV. In vitro bioassay of the vasoinhibitory activity of sera from patients suffering from peripheral ischaemia. Gen. Pharmacol., 15, 115–122, 1984.
17.
LeeG.T.C.A study of electrical stimulation of acupuncture locus Tsusanli (St.-36) on mesentric microcirculation, Am. J. Chin. Med., 2, 53–66, 1974.
18.
OmuraY.Patho-physiology of acupuncture treatment: Effects of acupuncture on cardiovascular and nervous systems. Acupuncture & Electro-Therap. Res. Int. J., 1, 55–141, 1975.
19.
OmuraY.Non-invasive circulatory evaluation and electroacupuncture and TES treatment of diseases difficult to treat in Western Medicine: 1) abnormal train circulation and blood pressure: cephalic hypertension or cephalic hypotension syndromes and their related conditions - insomnia, blindness due to macular degeneration & retinitis Pigmentosa, and some psychiatric problems; 2) severe lower extremity circulatory disturbances, with intractable pain, intermittent claudication, ulceration and/or severe diabetic neuropathy. Acupuncture & Electro-Therap. Res. Int. J., 8, 177–255, 1983.
20.
RattanS.SaidS.I.and GoyalR.K.Effect of vasoactive intestinal polypeptide (VIP) on the lower esophageal sphincter pressure (LESP) (39740), Proc. Soc. exp. Bioi. & Med., 155, 40–43, 1977.
21.
RocciaL.MilaniL.GuignoG.and RovereP.M.Patologia funzionale esofagea e terapia per agopuntura, Minerva Med., 72, 2215–2222, 1981.
22.
RosellS.ThorK.RökaeusA.NyquistO.., Plasma concentration of neurotensin-like immunoreactivity (NTLI) and lower esophageal sphincter (LES) pressure in man following infusion of (Gln')-neurotensin, Acta Physiol. Scand., 109, 369–375, 1980.
23.
UddmanR.AlumetsJ.and EdvinssonJ.., Peptidergic (VIP) innervation of the esophagus, Gastroenterology, 75, 5–8, 1978.
